Results from a trial of an mRNA vaccine for pancreatic cancer have shown that the vaccine reduces the chance of the cancer ...
A recent modification to the contract would have allowed Vaxart to invoice BARDA for the remaining $230 million or so for ...
A bill that would ban the use of mRNA vaccines, including for Covid-19, is on its way to the House floor after passing out of ...
In a significant development for pancreatic cancer treatment, a phase 1 clinical trial has highlighted the potential of ...
As global capital reassesses the investment value of innovative Chinese companies, the development of innovative vaccines in ...
There is new hope in the fight against pancreatic cancer after early trials showed that personalized mRNA vaccines can target ...
The Phase I data aligns with previous preclinical findings, showing over 95% protection in non-human primates, comparable to ...
COVID-19 vaccines target emerging variants, offering improved protection. Learn about their effectiveness, timing, and safety ...